Publications

Dr. Hajji at the Rocío Vázquez Foundation Scientific Conference to discuss epigenetics and chemoresistance in cancer and the opportunities of Precision Medicine.

We lead the Precision Medicine biomedical revolution

This represents a huge opportunity for both patients and the sector in economic and innovation terms

Publications

Links

Know our publications

HDAC6 regulates expression of the oncogenic driver EWSR1-FLI1 through the EWSR1 promoter in Ewing sarcoma

Synergistic Enhancement of Cancer Therapy Using HDAC Inhibitors: Opportunity for Clinical Trials

An inducible ectopic expression system of EWSR1-FLI1 as a tool for understanding Ewing sarcoma oncogenesis

Novel nuclear role of HDAC6 in prognosis and therapeutic target for colorectal cancer

Doxorubicin Improves Cancer Cell Targeting by Filamentous Phage Gene Delivery Vectors

Ketogenic diet and metabolic regulation of brain microglia

The renin angiotensin system (RAS) mediates bifunctional growth regulation in melanoma and is a novel target for therapeutic intervention

The bitter side of epigenetics: variability and resistance to chemotherapy

Gene-21. The ketogenic diet alters the epigenetic landscape of gbm to potentiate the effects of chemo and radiotherapy

Cationic lipid-based nanoparticles mediate functional delivery of acetate to tumor cells in vivo leading to significant anticancer effects

Synergy between histone deacetylase inhibitors and DNA-damaging agents is mediated by histone deacetylase 2 in colorectal cancer

Inhibition of Histone Deacetylation and DNA Methylation Improves Gene Expression Mediated by the Adeno-Associated Virus/Phage in Cancer Cells

Dr. Hajji Nabil

Epigenetics and Chemoresistance in Cancer

We lead the Precision Medicine biomedical revolution

Keyzell

Links

Newsletters